BriaCell Closes CEO Equity Investment

BriaCell Therapeutics (TSXV:BCT, OTCQB:BCTXF) completed a non-brokered private placement financing of 5,612,083 units, totaling $1,346,900. As quoted in the press release: Under the...

BriaCell Approved by FDA for BriaVax Testing

BriaCell Therapeutics (TSX VENTURE:BCT) (OTCQB:BCTXF) has been cleared by the FDA to begin an open-label Phase I/IIa trial of its...